Supplemental Data - topical steroids in mycosis fungoides

Supplemental Figure 1: Patient characteristics based on changes in mSWAT Left top. 73% (27/37) of patients had an improvement in mSWAT, while 27% (10/37) flared or did not respond to topical corticosteroid monotherapy. Left bottom: From the improved group, 45% had a complete response (mSWAT of 0), and 33% had a partial response (≥50% decrease in mSWAT) with prolonged topical corticosteroid use. Right top. Gender, MF stage, and age distribution in patients with reduced mSWAT. Right bottom. Gender, MF stage, and age distribution in patients with increased or unchanged mSWAT. Supplemental Figure 2: Changes in mSWAT based on Gender, Stage and Age. 37 patients were included in the Waterfall plot analysis and arranged in order from the greatest increase in mSWAT to the greatest decrease in mSWAT. Patients were stratified based on gender, stage and age.

补充图1：基于mSWAT变化的患者特征。左上亚图：73%（27/37）的患者mSWAT评分得到改善，另有27%（10/37）的患者病情加重或对单用外用糖皮质激素治疗无应答。左下亚图：在改善组中，45%的患者获得完全应答（mSWAT评分为0），33%的患者获得部分应答（mSWAT评分下降≥50%），且需延长外用糖皮质激素的使用疗程。右上亚图：mSWAT评分降低患者的性别、蕈样肉芽肿（Mycosis Fungoides, MF）分期及年龄分布。右下亚图：mSWAT评分升高或无变化患者的性别、MF分期及年龄分布。补充图2：基于性别、分期与年龄的mSWAT评分变化。本瀑布图分析纳入37例患者，按mSWAT评分变化从升高幅度最大到降低幅度最大的顺序排列。研究按性别、分期及年龄对患者进行分层。